477 related articles for article (PubMed ID: 11312335)
1. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.
Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE
J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of neutralizing antibodies against Ebola virus infection.
Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
[TBL] [Abstract][Full Text] [Related]
3. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
4. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
Bray M; Davis K; Geisbert T; Schmaljohn C; Huggins J
J Infect Dis; 1999 Feb; 179 Suppl 1():S248-58. PubMed ID: 9988191
[TBL] [Abstract][Full Text] [Related]
5. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.
Huggins J; Zhang ZX; Bray M
J Infect Dis; 1999 Feb; 179 Suppl 1():S240-7. PubMed ID: 9988190
[TBL] [Abstract][Full Text] [Related]
6. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
Wilson JA; Bray M; Bakken R; Hart MK
Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.
Gibb TR; Bray M; Geisbert TW; Steele KE; Kell WM; Davis KJ; Jaax NK
J Comp Pathol; 2001 Nov; 125(4):233-42. PubMed ID: 11798240
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
9. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
Kobinger GP; Feldmann H; Zhi Y; Schumer G; Gao G; Feldmann F; Jones S; Wilson JM
Virology; 2006 Mar; 346(2):394-401. PubMed ID: 16356525
[TBL] [Abstract][Full Text] [Related]
10. Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.
Kudoyarova-Zubavichene NM; Sergeyev NN; Chepurnov AA; Netesov SV
J Infect Dis; 1999 Feb; 179 Suppl 1():S218-23. PubMed ID: 9988187
[TBL] [Abstract][Full Text] [Related]
11. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
Geisbert TW; Hensley LE; Geisbert JB; Jahrling PB
Virology; 2002 Feb; 293(1):15-9. PubMed ID: 11853394
[TBL] [Abstract][Full Text] [Related]
12. Development of a broad-spectrum antiviral with activity against Ebola virus.
Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S
Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.
Jones SM; Stroher U; Fernando L; Qiu X; Alimonti J; Melito P; Bray M; Klenk HD; Feldmann H
J Infect Dis; 2007 Nov; 196 Suppl 2():S404-12. PubMed ID: 17940977
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection.
Broen JJ; Cafruny WA
Reg Immunol; 1993; 5(1):44-52. PubMed ID: 8347469
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
Vanderzanden L; Bray M; Fuller D; Roberts T; Custer D; Spik K; Jahrling P; Huggins J; Schmaljohn A; Schmaljohn C
Virology; 1998 Jun; 246(1):134-44. PubMed ID: 9657001
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human monoclonal antibodies to Ebola virus.
Maruyama T; Parren PW; Sanchez A; Rensink I; Rodriguez LL; Khan AS; Peters CJ; Burton DR
J Infect Dis; 1999 Feb; 179 Suppl 1():S235-9. PubMed ID: 9988189
[TBL] [Abstract][Full Text] [Related]
17. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.
Ksiazek TG; Rollin PE; Williams AJ; Bressler DS; Martin ML; Swanepoel R; Burt FJ; Leman PA; Khan AS; Rowe AK; Mukunu R; Sanchez A; Peters CJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S177-87. PubMed ID: 9988182
[TBL] [Abstract][Full Text] [Related]
18. Development of a preventive vaccine for Ebola virus infection in primates.
Sullivan NJ; Sanchez A; Rollin PE; Yang ZY; Nabel GJ
Nature; 2000 Nov; 408(6812):605-9. PubMed ID: 11117750
[TBL] [Abstract][Full Text] [Related]
19. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies.
Ye L; Lin J; Sun Y; Bennouna S; Lo M; Wu Q; Bu Z; Pulendran B; Compans RW; Yang C
Virology; 2006 Aug; 351(2):260-70. PubMed ID: 16678231
[TBL] [Abstract][Full Text] [Related]
20. Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice.
Patel A; Zhang Y; Croyle M; Tran K; Gray M; Strong J; Feldmann H; Wilson JM; Kobinger GP
J Infect Dis; 2007 Nov; 196 Suppl 2():S413-20. PubMed ID: 17940978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
